Chardan analyst Keay Nakae lowered the firm’s price target on Femasys (FEMY) to $8 from $10 and keeps a Buy rating on the shares post the Q3 report. The lowered target reflects a higher projected future share count as modeled future capital raises, including one in Q1 of 2025, are expected to be more dilutive due to the current share price, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY: